NORTHWAY MEDICAL CENTRE — All Prescriptions & Medications — Page 8
Practice Code: M87037 | DUDLEY, DY3 3QY
Showing results 351-400 of 568
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 38 | 202.5K | £2.7K | +445.4% ▲ |
| Diclofenac sodium | 38 | 2,400 | £1.7K | +58.6% ▲ |
| Rabeprazole sodium | 37 | 3,360 | £582 | -28.3% ▼ |
| Bempedoic acid/Ezetimibe | 37 | 1,400 | £2.6K | -39.4% ▼ |
| Lithium carbonate | 37 | 1,760 | £261 | -70.8% ▼ |
| Domperidone | 37 | 2,166 | £47 | +3.7% ▲ |
| Biphasic isophane insulin | 37 | 420 | £1.7K | -66.8% ▼ |
| Sodium chloride | 37 | 1,440 | £919 | +24.4% ▲ |
| Brinzolamide and timolol | 36 | 275 | £376 | -4.7% ▼ |
| 36 | 12.8K | £188 | +113.1% ▲ | |
| Moxonidine | 35 | 2,114 | £284 | -37.1% ▼ |
| Valsartan | 35 | 1,540 | £359 | -40.6% ▼ |
| Ipratropium bromide | 35 | 1,477 | £446 | +21.8% ▲ |
| Alprostadil | 35 | 116 | £1.1K | +104.7% ▲ |
| 35 | 739 | £425 | +73.1% ▲ | |
| 35 | 1,750 | £300 | +56.5% ▲ | |
| Metoprolol tartrate | 34 | 2,886 | £277 | -33.0% ▼ |
| Ivabradine | 34 | 3,640 | £1.2K | -64.2% ▼ |
| Erythromycin | 34 | 1,530 | £627 | +150.4% ▲ |
| 34 | 750 | £50 | -37.4% ▼ | |
| Desloratadine | 33 | 1,452 | £139 | +14.4% ▲ |
| Clonidine hydrochloride | 33 | 4,748 | £473 | -38.1% ▼ |
| Travoprost | 32 | 1,213 | £304 | -32.1% ▼ |
| Timolol and bimatoprost | 32 | 804 | £645 | -78.9% ▼ |
| Adapalene and benzoyl peroxide | 32 | 1,695 | £730 | -40.1% ▼ |
| Acetylcysteine | 31 | 1,160 | £203 | -56.6% ▼ |
| Oral rehydration salts | 31 | 344 | £154 | +7.3% ▲ |
| Fluticasone furoate/vilanterol | 30 | 40 | £908 | -80.6% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 30 | 2,280 | £266 | -25.3% ▼ |
| 30 | 2,046 | £3.7K | -24.8% ▼ | |
| 30 | 200 | £376 | +120.9% ▲ | |
| 29 | 740 | £408 | -11.7% ▼ | |
| Dipyridamole | 28 | 2,764 | £730 | +9.1% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 28 | 16.8K | £261 | +22.2% ▲ |
| 28 | 6,850 | £361 | -26.6% ▼ | |
| 28 | 2,638 | £405 | +4.2% ▲ | |
| 28 | 480 | £1.6K | -8.9% ▼ | |
| 28 | 2,850 | £356 | +2.5% ▲ | |
| 28 | 2,530 | £571 | +8.6% ▲ | |
| 28 | 1,120 | £5.3K | +128.3% ▲ | |
| Flecainide acetate | 27 | 2,464 | £79 | -65.4% ▼ |
| Levocetirizine | 27 | 918 | £118 | +73.3% ▲ |
| Desmopressin acetate | 27 | 1,016 | £1.0K | -48.2% ▼ |
| Alfuzosin hydrochloride | 27 | 1,488 | £411 | -62.3% ▼ |
| 27 | 165 | £724 | -27.3% ▼ | |
| 27 | 261 | £655 | +359.1% ▲ | |
| Sotalol hydrochloride | 26 | 2,968 | £87 | -63.0% ▼ |
| Lacosamide | 26 | 1,680 | £925 | -51.6% ▼ |
| Rotigotine | 26 | 714 | £2.6K | -3.6% ▼ |
| Tolterodine | 26 | 2,016 | £246 | -82.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.